Late complications of clinical Clostridium Histolyticum collagenase use in Dupuytren's disease

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Rozen, Warren M ^a,b   Edirisinghe, Yasith ^a,b   Crock, John ^a,b  

^a DANDENONG HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLOSTRIDIOPEPTIDASE A;

ADHESIOLYSIS; ADHESION; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONSERVATIVE TREATMENT; CROSS-SECTIONAL STUDY; DRUG EFFICACY; DRUG SAFETY; DUPUYTREN CONTRACTURE; FASCIOTOMY; FOLLOW UP; HUMAN; HUMAN TISSUE; INCIDENCE; MALE; NEUROLYSIS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; SCAR FORMATION; SOFT TISSUE RECONSTRUCTION; SURGICAL TECHNIQUE; TENDOLYSIS;

CICATRIX; CLOSTRIDIUM HISTOLYTICUM; COHORT STUDIES; DUPUYTREN CONTRACTURE; FOLLOW-UP STUDIES; HAND DEFORMITIES, ACQUIRED; HUMANS; MALE; MICROBIAL COLLAGENASE; PAIN; TISSUE ADHESIONS;

EID: 84865104503     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043406     Document Type: Article

References (12)

1. Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, et al. ((2009)) Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Eng J Med 361 (10):: 968--979.
2. Amadio PC, ((2009)) What's new in hand surgery. J Bone Joint Surg (Am) 91:: 496--502.
3. Desai SS, Hentz VR, ((2010)) Collagenase clostridium histolyticum for Dupuytren's contracture. Expert Opin Biol Therapy 10(9):: 1395--1404.
4. Badalamente MA, Hurst LC, ((2007)) Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg (Am) 32:: 767--774.
5. Saar JD, Grothaus PC, ((2000)) Dupuytren's Disease: An Overview. Plas Reconstr Surg 106(1):: 125--134.
6. Rayan GM, ((2007)) Dupuytren's Disease: Anatomy, Pathology, Presentation and Treatment. J Bone Joint Surg (Am) 89 (1):: 190--198.
7. Townley WA, Baker R, Grobbelaar AO, ((2006)) Dupuytren's contracture unfolded. BMJ 332:: 397--400.
8. Hindocha S, McGrouther DA, ((2009)) Epidemiological Evaluation of Dupuytren's Disease - Incidence and Prevalence Rates in Relation to Etiology. Hands 4:: 256--269.
9. Bayat A, McGrouther DA, ((2006)) Management of Dupuytren's disease - Clear advise for an elusive condition. Ann Roy Coll Surg Engl 88:: 3--8.
10. Rydevik B, Ehira T, Linder L, Olmarker K, Romanus M, et al. ((1989)) Microvascular response to locally injected collagenase. Scand J Plast Reconstr Surg 23:: 17--21.
11. Badalamente MA, Hurst LC, Hentz VR, ((2002)) Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg (Am) 27:: 788--798.
12. Suomalainen K, Sorsa T, Golub L, Ramamurthy N, Lee HM, et al. ((1992)) Specificity of the anticollagenase action of tetracyclines; relevance to their anti-inflammatory potential. Antimicr Agents Chemotherapy 36:: 227--229.